Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer
Yuan Yuan(City of Hope), John H. Yim(City of Hope)
Cited by 33
Related Papers
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
|Journal of Hematology & Oncology|2011|120
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
|Molecular Cancer|2015|93
IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition
|Cancer Biology & Therapy|2015|35
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin
|International Journal of Molecular Sciences|2025|2